Global Stem Cell Therapy Market 2022-2028

December 2022 | 62 pages | ID: G0E9C54E3121EN
Gen Consulting Company

Abstracts

The global stem cell therapy market size is projected to grow by USD 5.6 billion from 2022 to 2028, registering a CAGR of 10.8 percent, according to a new report by Gen Consulting Company.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global stem cell therapy market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the stem cell therapy industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the cell source, type, application, end user, and region. The global market for stem cell therapy can be segmented by cell source: adipose tissue, bone marrow, neural, embryo and cord blood-derived, IPSCs, PPSC. The adipose tissue segment was the largest contributor to the global stem cell therapy market in 2021. Stem cell therapy market is further segmented by type: allogeneic, autologous. According to the research, the allogeneic segment had the largest share in the global stem cell therapy market. Based on application, the stem cell therapy market is segmented into: cancer, diabetes, musculoskeletal disorders, cardiovascular, gastrointestinal diseases, others. The diabetes segment held the largest revenue share in 2021. On the basis of end user, the stem cell therapy market also can be divided into: hospital and clinic, ambulatory surgical center, research center, others. Globally, the hospital and clinic segment made up the largest share of the stem cell therapy market. Stem cell therapy market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation

By cell source: adipose tissue, bone marrow, neural, embryo and cord blood-derived, IPSCs, PPSC

By type: allogeneic, autologous

By application: cancer, diabetes, musculoskeletal disorders, cardiovascular, gastrointestinal diseases, others

By end user: hospital and clinic, ambulatory surgical center, research center, others

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report explores the recent developments and profiles of key vendors in the Global Stem Cell Therapy Market, including Fresenius Medical Care AG & Co. KGaA, NextCell Pharma AB, Novo Nordisk A/S, Sernova Corp., Vertex Pharmaceuticals Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global stem cell therapy market.
• To classify and forecast the global stem cell therapy market based on cell source, type, application, end user, region.
• To identify drivers and challenges for the global stem cell therapy market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global stem cell therapy market.
• To identify and analyze the profile of leading players operating in the global stem cell therapy market.

Why Choose This Report

• Gain a reliable outlook of the global stem cell therapy market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY CELL SOURCE

Adipose tissue
Bone marrow
Neural
Embryo and cord blood-derived
IPSCs
PPSC

PART 6. MARKET BREAKDOWN BY TYPE

Allogeneic
Autologous

PART 7. MARKET BREAKDOWN BY APPLICATION

Cancer
Diabetes
Musculoskeletal disorders
Cardiovascular
Gastrointestinal diseases
Others

PART 8. MARKET BREAKDOWN BY END USER

Hospital and clinic
Ambulatory surgical center
Research center
Others

PART 9. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 10. KEY COMPANIES

Fresenius Medical Care AG & Co. KGaA
NextCell Pharma AB
Novo Nordisk A/S
Sernova Corp.
Vertex Pharmaceuticals Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER